Rigel Pharmaceuticals, Inc. (RIGL)
30.58
+0.50
(+1.66%)
USD |
NASDAQ |
Jun 09, 12:46
Rigel Pharmaceuticals Market Cap : 565.17M for June 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Pfizer Inc. | 147.01B |
| Madrigal Pharmaceuticals, Inc. | 10.87B |
| CytomX Therapeutics, Inc. | 618.25M |
| ACADIA Pharmaceuticals, Inc. | 3.683B |
| Alnylam Pharmaceuticals, Inc. | 39.65B |
Market Cap Related Metrics
| PE Ratio | 1.633 |
| PS Ratio | 1.959 |
| PEG Ratio | 0.0020 |
| Price to Book Value | 1.413 |
| Price to Free Cash Flow | 7.406 |
| Price | 30.58 |
| Earnings Yield | 61.22% |
| PEGY Ratio | 0.0020 |
| Operating PE Ratio | 4.713 |
| Normalized PE Ratio | 1.633 |